 |
 |
 |
 |
 |
Dave Ennist
dave.ennist@novartis.pharma.com
(301)258-4673
Genetic Therapy, Inc., a Novartis company, is the leader in the
development of human gene therapy products for the treatment of
genetic and acquired diseases. Using this novel approach, genes are
inserted into cells to produce therapeutic proteins in the body.
Founded in 1986, Genetic Therapy and its collaborators represent one
of the largest groups of scientists dedicated to research and
development in this field. The Company's product development target
programs include: cancers, hemophilia and cystic fibrosis. We are
currently in a Phase III Clinical Trial for brain tumors.
Research Associate III
We are seeking a senior technician to develop technologies for gene
transfer to the lung. This individual must be well versed in small
animal surgical procedures and be able to perform tissue culture and
molecular techniques. A working knowledge of cellular and humoral
immune assays, including flow cytometry, is essential. The successful
applicant will be self-motivated, able to work independently and in a
team setting, and have good written and oral communication skills.
We currently have over 200 employees located in the Washington, DC
area. We offer excellent benefits and competitive salaries. Please
send or fax resume to:
Please specify job code 107-013-7
Fax: (301) 948-0503
Email: gti.jobs@pharma.novartis.com Mail: Human Resources
Genetic Therapy, Inc
938 Clopper Road
Gaithersburg, MD 20878
|
|
|
|
|
|
CD-ROM Vol 3 was produced by Monica M. Shively and other staff at the
Purdue University Cytometry Laboratories and distributed free of charge
as an educational service to the cytometry community.
If you have any comments please direct them to
Dr. J. Paul Robinson, Professor & Director,
PUCL, Purdue University, West Lafayette, IN 47907.
Phone: (765)-494-0757;
FAX(765) 494-0517;
Web